CollPlant Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	26.67	29.65	13.15	3.33	3.79	5.35	4.95	1.06
Short-Term Investments	0	0	30.15	0	0	0	0	0
Cash & Cash Equivalents	26.67	29.65	43.3	3.33	3.79	5.35	4.95	1.06
Cash Growth	-10.05%	-31.52%	1199.10%	-12.08%	-29.19%	8.09%	369.24%	-
Receivables	0.39	0.55	0.69	1.07	0.35	0.53	0.12	0.11
Inventory	0.71	1.43	1.08	1.26	0.89	0.81	0.19	0.14
Other Current Assets	0.24	0.02	0.01	0.01	0.01	0.47	0.96	0.95
Total Current Assets	28.02	31.66	45.09	5.68	5.04	7.17	6.23	2.24
Property, Plant & Equipment	5.86	5.68	5.68	4.9	5.54	1.41	1	1.11
Goodwill and Intangibles	0.19	0.25	0.24	0.08	0	0	0.4	0.45
Other Long-Term Assets	0.06	0.19	0.21	0.18	0.17	0.17	0.17	0.2
Total Long-Term Assets	6.1	6.11	6.14	5.17	5.71	1.58	1.57	1.77
Total Assets	34.13	37.77	51.22	10.84	10.75	8.75	7.8	4.01
Accounts Payable	0.98	1.13	1.03	0.8	0.83	0.62	1.38	1.52
Deferred Revenue	0	0	0.03	0.21	0.94	1.95	0	0
Current Debt	0.62	0.53	0.52	0.44	0.48	0.02	0	0
Other Current Liabilities	1.65	1.44	1.43	1.94	1.2	-0.36	-0.02	0.37
Total Current Liabilities	3.25	3.11	3.01	3.39	3.46	2.23	1.37	1.89
Long-Term Debt	2.54	2.38	3.09	2.95	3.14	0.02	3.51	0
Other Long-Term Liabilities	0	0	0	0.03	0.07	1.08	0.39	0.69
Total Long-Term Liabilities	2.54	2.38	3.09	2.98	3.21	1.1	3.9	0.69
Total Liabilities	5.79	5.49	6.1	6.36	6.66	3.33	5.27	2.58
Total Debt	3.16	2.91	3.61	3.39	3.62	0.04	3.51	0
Debt Growth	8.52%	-19.32%	6.49%	-6.36%	8122.73%	-98.75%	-	-
Retained Earnings	-96.74	-89.72	-72.8	-73.03	-67.26	-56.1	-48.48	-43.9
Comprehensive Income	-0.97	-0.97	-0.97	-0.97	-0.97	-0.97	0	0
Shareholders' Equity	28.34	32.28	45.12	4.48	4.09	5.42	2.53	1.43
Net Cash / Debt	23.52	26.74	39.69	-0.06	0.17	5.31	1.44	1.06
Net Cash / Debt Growth	-12.07%	-32.62%	-	-	-96.74%	268.88%	36.37%	-
Net Cash Per Share	2.06	2.42	3.32	-0.01	0.03	1.21	0.54	0.52
Working Capital	24.77	28.55	42.07	2.29	1.58	4.94	4.86	0.35
Book Value Per Share	2.49	2.93	4.53	0.65	0.82	1.24	0.95	0.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).